Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.
about
Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune responseVaccines for Pseudomonas aeruginosa: a long and winding roadRoles of the carboxy-terminal half of Pseudomonas aeruginosa major outer membrane protein OprF in cell shape, growth in low-osmolarity medium, and peptidoglycan associationProtection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosaPurification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1.Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli.Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.Synthetic peptides representing two protective, linear B-cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific.Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin FBordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes.A 36-kilodalton Brucella abortus cell envelope protein is encoded by repeated sequences closely linked in the genomic DNAImmunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse modelEffectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in miceProtection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi.Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model.Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infectionCharacterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosaImmunoglobulin M and immunoglobulin G responses in BALB/c mice to conjugated outer membrane extracts of four Salmonella serotypesAnalyses of gonococcal lipopolysaccharide in whole-cell lysates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis: stable association of lipopolysaccharide with the major outer membrane protein (protein I) of Neisseria gonorrhoeae.Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum.Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa.Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences.Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.Competitive enzyme immunoassay for antibodies to a 43,000-molecular-weight Francisella tularensis outer membrane protein for the diagnosis of tularemia.Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever.Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts.Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man.
P2860
Q24650974-9399CAF5-07CB-41E7-BD14-4D0DA0D33C06Q26852817-0968E477-C3CE-48CC-B740-2239C3BA0D1BQ30176129-F4E7CCEF-E7C4-434A-A888-4BD6B8386A8AQ33523622-C5A786D5-59DA-4EDC-AF33-5EA6EC07597BQ33760042-6869E897-5914-433F-A9FC-545A24FD19AFQ34000731-D68B390C-D361-4F36-A987-31FBC70798BAQ34007482-0E838EE8-01B9-4573-9F5B-100DA9A4BA38Q34540505-A63749C3-229F-4946-A283-813E463186F8Q35206982-68791A5B-BBD0-4F20-851C-2AF4DF849060Q35410420-56C2A2B0-92E0-46A8-8DA4-A428FA815432Q35419334-589CBBCB-6633-4078-A54B-28356713175DQ35766685-D513FB6C-1ADB-430D-A367-55DABF49AB36Q36283982-F4B32519-534B-4FDA-88DB-52AC0820CE7DQ36433676-48582FFD-7694-47BC-8BCE-BF2ED7A37ACEQ36676050-3C19DE53-49E1-4C2F-85D2-BB99C8C5793CQ36985634-39D09D03-7F30-48F1-A3DF-B5F58829638BQ36988356-9B471D0C-D7B7-4607-BACA-8FC909B2BC60Q37000487-7E1C7FC7-28B2-4AA3-BC96-D9646DEA0C77Q37000969-BE25AEF2-7CF9-48BF-BEBE-E7E28205A57EQ37003335-C498A70E-1B35-4168-9E0A-14198215B922Q37013973-22EF753D-79A2-4A29-A25B-02B686E11286Q37028395-137B34C6-F110-4F6B-B09F-A94619885E40Q37032900-540A6EC3-9661-4725-8CD8-58145E2D3C6CQ37038638-A55DA840-4300-4FDD-A25A-6493C4BA82C9Q37053810-6E6727F5-D6D7-437B-B167-C03718819739Q37212352-43B809F5-3E95-4EB0-8E64-E23277F37238Q39820660-C4439C83-4903-4F55-BE75-84F8827B93BDQ39859766-D3824D8F-FDCE-42E3-BED0-70599C6CBB80Q40147770-924AC024-C63C-46D1-8DC2-1E744A01CA1EQ40157644-7D1B26A9-46AF-4727-9317-DB7810643D60Q40172509-92E5D065-EDCD-4EB5-92CA-007134E15E47Q40199283-54F5634E-6946-4257-A28C-D5D8A6BA260BQ40200159-C98C98BD-DF0C-4DB5-9D12-CDD1DA51B438Q40206671-02D78563-63C0-4180-BB45-E45A05A5792AQ42840176-DEDF3ACD-425B-40DA-AB2C-2534EDF8FACE
P2860
Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Use of a purified outer membra ...... a protective vaccine in mice.
@en
type
label
Use of a purified outer membra ...... a protective vaccine in mice.
@en
prefLabel
Use of a purified outer membra ...... a protective vaccine in mice.
@en
P2093
P2860
P1476
Use of a purified outer membra ...... s a protective vaccine in mice
@en
P2093
Gilleland HE Jr
Matthews JM
P2860
P407
P577
1984-04-01T00:00:00Z